The medical community is excited with anticipation surrounding retatrutide, a novel dual GIP and GLP-1 receptor that’s showing significant efficacy in clinical trials for addressing obesity. Unlike some existing weight loss solutions, retatrutide appears to deliver a significant substantial loss in body size and benefit metabolic health, particu… Read More